The test may be able to personalise chemotherapy, preventing patients from potentially going through the harsh treatment for ...

Over a median follow-up of 7 years, breast cancer survivors had an 8% lower risk of Alzheimer's dementia compared with ...

Watch the “What This Means" segment here HOUSTON, June 18, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ( ...

Cancer Research UK-funded scientists at the University of Cambridge, in collaboration with the Spanish National Cancer ...

Tens of thousands of cancer patients going through gruelling chemotherapy could have DNA test to predict which form of the ...

Test, developed by University of Cambridge, looks at structure of tumour DNA and forecasts whether it will resist treatment ...

Oncologists vary widely in treating DLBCL with cardiomyopathy, often diverging from guidelines due to limited evidence on ...

VANFLYTA (quizartinib) has been approved by Health Canada for use in combination with standard cytarabine and anthracycline ...

New DNA test predicts chemotherapy resistance before treatment, potentially sparing patients from ineffective toxic drugs.

Research led by Samsung Medical Center finds breast cancer survivors exhibit an 8% lower risk of Alzheimer's dementia (AD) ...

Chemotherapy seeks to destroy tumor cells and has been a standard treatment for cancer for decades. However, it doesn't ...